Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-20 16:11 |
Information relative au nombre total de droits de vote et d’actions composant l…
|
French | 231.9 KB | ||
| 2024-11-13 17:30 |
Crossject démontre à nouveau la facilité d’utilisation de son auto-injecteur ZE…
|
French | 263.4 KB | ||
| 2024-11-13 17:30 |
Crossject’s ZENEO® Auto-Injector's usability further demonstrated in extreme HA…
|
English | 215.5 KB | ||
| 2024-10-22 07:30 |
Crossject annonce des progrès majeurs dans la fabrication de son traitement d’u…
|
French | 230.9 KB | ||
| 2024-10-22 07:30 |
Crossject reports strong manufacturing progress with its epilepsy rescue therap…
|
English | 179.2 KB | ||
| 2024-10-07 19:00 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 234.2 KB | ||
| 2024-10-07 19:00 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 230.6 KB | ||
| 2024-10-07 19:00 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 232.3 KB | ||
| 2024-09-26 07:30 |
Crossject announces its eligibility for France’s PEA-PME investment scheme
|
English | 208.8 KB | ||
| 2024-09-26 07:30 |
Crossject annonce son éligibilité au dispositif d’investissement PEA-PME
|
French | 198.9 KB | ||
| 2024-09-23 18:00 |
Crossject présente ses résultats financiers et les faits marquants de ses activ…
|
French | 284.2 KB | ||
| 2024-09-23 18:00 |
Crossject reports financial results and business highlights for the first six m…
|
English | 261.2 KB | ||
| 2024-09-17 17:30 |
Crossject publiera ses résultats financiers du premier semestre et organisera u…
|
French | 219.0 KB | ||
| 2024-09-17 17:30 |
Crossject to report first-half 2024 financial results and host webcast on Septe…
|
English | 224.3 KB | ||
| 2024-08-22 07:30 |
Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wa…
|
French | 234.7 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
